[Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber]

Abstract

Epsilon aminocaproic acid (EACA) is an antifibrinolytic agent currently used in the management of traumatic hyphema. It is effective in reducing the rebleed rate, but a long-standing blood clot in the anterior chamber predisposes to complications, such as corneal blood staining and elevated intraocular pressure. We assume that a large blood clot in the anterior chamber might be a contraindication to the use of EACA.